Documents Eric Van Cutsem*, I. Lang, G. Folprecht, M. Nowacki , S. Cascinu, I. Shchepotin , J. Maurel,

Cetuximab plus FOLFIRI in the treatment of metastatic colorectal cancer: the influence of KRAS and BRAF biomarkers on outcome: updated data from the CRYSTAL trial Eric Van…